Fig. 1: Graphical study overview.
This study evaluated 1,031 COVID-19 patients between the ages of 18 and 96 enrolled in the IMPACC cohort at 20 hospitals across the United States. Blood (PBMCs, plasma and serum) and nasal swab samples were collected at up to 6 visits over 28 days and processed for RNA sequencing, proteomics, mass cytometry, and serology.